Oral OKT3 in Combination With Beta-D-Glucosylceramide

NCT00619372 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: OKT3
DRUG: OKT3, GC
DRUG: OKT3
DRUG: OKT3, GC
DRUG: OKT3
DRUG: GC

Sponsor

Hadassah Medical Organization